Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence

Summary

The purpose of this study is to determine whether guanfacine represents a tolerable, potentially effective pharmacotherapy option for cannabis dependence. Interested in seeing whether guanfacine treatment reduces marijuana consumption, withdrawal symptoms, and craving as compared to baseline.

Timeline

Start

2012-02

Primary completion

2016-04

Completion

2016-10

Drugs

Indications